Analysts at Morgan Stanley (MS) are out with a report this morning upgrading shares of ImmunoGen, Inc. (IMGN) with an ‘Equal-Weight‘ from ‘Underweight‘ rating.
Immunogen Inc. shares have a t-12 price-to-sales ratio of 9.84. EPS for the same period is ($0.66).
In the past 52 weeks, shares of Waltham, Massachusetts-based biotechnology company have traded between a low of $5.34 and a high of $15.35 and are now at $14.75. Shares are down 22.39% year-over-year ; up 47.21% year-to-date.
Analysts at Piper Jaffray upgraded their rating on the shares of Renewable Energy Group, Inc. (REGI). In a research note published on Monday, the firm lifted the name with an ‘Overweight‘ from ‘Neutral‘ rating.
On valuation measures, Renewable Energy Group Inc. shares are currently priced at 10.77x this year’s forecasted earnings. Ticker has a PEG and forward P/E ratio of (2.13) and 12.38, respectively. T-12 price/sales is 0.36 while EPS is $1.08. Currently there are 2 analysts that rate REGI a ‘Buy‘, 2 rate it a ‘Hold‘. No analyst rates it a ‘Sell‘. REGI has a median Wall Street price target of $13.00 with a high target of $17.00.
Oncothyreon Inc (ONTY) was reiterated a ‘Buy’ by Jefferies analysts on Monday. The broker also raised its price target on the stock to $5 from $2.50.
ONTY is up $0.73 at $4.15 on heavy volume. Midway through trading Monday, 26.50 million shares of Oncothyreon Inc. have exchanged hands as compared to its average daily volume of 5.50 million shares. The stock has ranged between $3.78-$4.69 after having opened the day at $4.65 as compared to the previous trading day’s close of $3.42.
In the past 52 weeks, shares of Seattle, Washington-based company have traded between a low of $1.41 and a high of $4.69. Shares are up 17.93% year-over-year and 80% year-to-date.
Humana Inc. (HUM) was reiterated as ‘Hold’ with a $220 from $155 price target on Monday by Deutsche Bank (DB).
HUM is currently printing a higher than average trading volume with the issue trading 3.06 million shares, compared to the average volume of 1.62 million. The stock began trading this morning at $213.15 to currently trade 0.58% higher from the prior days close of $214.65. On an intraday basis it has gotten as low as $210.67 and as high as $217.00.
HUM shares have advanced 27.73% in the last 4 weeks and 30.79% in the past three months. Over the past 5 trading sessions the stock has gained 20.08%.
The Louisville, Kentucky-based company, which is currently valued at $32.39 billion, has a median Wall Street price target of $178.50 with a high target of $200.00. Humana Inc. is up 73.68% year-over-year, compared with a 9.48% gain in the S&P 500.